Gold continues to press against the $4,200 resistance zone, with a breakout above $4,250 signaling further upside while pullbacks above $3,950 remain attractive to buyers.
Full FDA approval for one of its drugs, an excellent earnings report, and a deep pipeline support the bullish trend. Is there more room to the upside for Amgen?